Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma
- Type
- Retraction
- Notice date
- 6/21/2023 0:00
- Journal
- Disease Markers
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9826032
- Original paper DOI
- 10.1155/2022/2483816
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Unreliable Results and/or Conclusions